These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 23623934

  • 1. Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
    Colloton M, Shatzen E, Wiemann B, Starnes C, Scully S, Henley C, Martin D.
    Eur J Pharmacol; 2013 Jul 15; 712(1-3):8-15. PubMed ID: 23623934
    [Abstract] [Full Text] [Related]

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.
    Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449
    [Abstract] [Full Text] [Related]

  • 4. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy.
    Tfelt-Hansen J, Chattopadhyay N, Yano S, Kanuparthi D, Rooney P, Schwarz P, Brown EM.
    Endocrinology; 2004 Mar 01; 145(3):1211-7. PubMed ID: 14645111
    [Abstract] [Full Text] [Related]

  • 5. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G, Burtis WJ.
    Endocrinology; 1990 Sep 01; 127(3):1444-9. PubMed ID: 2387260
    [Abstract] [Full Text] [Related]

  • 6. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, Akatsu T, Nagata N, Kasahara T, Ohkawa H.
    J Bone Miner Res; 1993 Jul 01; 8(7):849-60. PubMed ID: 8352067
    [Abstract] [Full Text] [Related]

  • 7. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM, Morris CA, Mitnick MA, Insogna KL.
    J Bone Miner Res; 1990 Oct 01; 5(10):1037-41. PubMed ID: 1964358
    [Abstract] [Full Text] [Related]

  • 8. Regulation of parathyroid hormone-related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500.
    Liu B, Goltzman D, Rabbani SA.
    Endocrinology; 1993 Apr 01; 132(4):1658-64. PubMed ID: 8462465
    [Abstract] [Full Text] [Related]

  • 9. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun 01; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 10. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide.
    Rabbani SA, Gladu J, Liu B, Goltzman D.
    Endocrinology; 1995 Dec 01; 136(12):5416-22. PubMed ID: 7588290
    [Abstract] [Full Text] [Related]

  • 11. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU.
    J Ren Nutr; 2006 Jul 01; 16(3):253-8. PubMed ID: 16825031
    [Abstract] [Full Text] [Related]

  • 12. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy.
    Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM.
    Biochem Biophys Res Commun; 2000 Mar 16; 269(2):427-32. PubMed ID: 10708570
    [Abstract] [Full Text] [Related]

  • 13. Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report.
    Faiq S, Lavelle K, Hu T, Shoback D, Ku G.
    BMC Endocr Disord; 2023 Jun 16; 23(1):133. PubMed ID: 37328745
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl.
    Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, Colloton M, Karbon W, Scherrer J, Shatzen E, Rishton G, Scully S, Qi M, Harris R, Lacey D, Martin D.
    J Pharmacol Exp Ther; 2004 Feb 16; 308(2):627-35. PubMed ID: 14593085
    [Abstract] [Full Text] [Related]

  • 15. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S, Caverzasio J, Rizzoli R, Bonjour JP.
    J Clin Invest; 1986 Jul 16; 78(1):319-22. PubMed ID: 3013941
    [Abstract] [Full Text] [Related]

  • 16. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA, Yoneda T, Yates AJ, Mundy GR.
    J Clin Endocrinol Metab; 1993 Jul 16; 77(1):40-5. PubMed ID: 8325957
    [Abstract] [Full Text] [Related]

  • 17. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
    Yaghoobian J, Morieux C, Denne MA, Bouizar Z, Ureña P, de Vernejoul MC.
    Horm Metab Res; 1998 May 16; 30(5):249-55. PubMed ID: 9660083
    [Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocaña A, Wisniewski SR, Stewart AF.
    J Clin Endocrinol Metab; 2001 Apr 16; 86(4):1525-31. PubMed ID: 11297578
    [Abstract] [Full Text] [Related]

  • 19. The role of calcium-sensing receptor and signalling pathways in the pathophysiology in two in vitro models of malignant hypercalcemia: the rat rice H-500 Leydig testis cancer and prostate cancer (PC-3) cells. Expression and regulation of pituitary tumor transforming gene in Leydig testis cancer and astrocyte and astrocytoma cells.
    Tfelt-Hansen J.
    Dan Med Bull; 2008 Feb 16; 55(1):17-46. PubMed ID: 18321443
    [Abstract] [Full Text] [Related]

  • 20. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
    Henderson J, Bernier S, D'Amour P, Goltzman D.
    Endocrinology; 1990 Sep 16; 127(3):1310-8. PubMed ID: 2167215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.